OOIR: Observatory of International Research

Papers

(The median citation count of Seminars in Immunopathology is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Learning cell identity in immunology, neuroscience, and cancer	109
Micro-to multi-chimerism: the multiple facets of a singular phenomenon	83
Vascular galectins in tumor angiogenesis and cancer immunity	75
Multiparameter single-cell proteomic technologies give new insights into the biology of ovarian tumors	74
Combination immunotherapy with synthetic long peptides and chemotherapy or PD-1 blocker for cancers caused by human papilloma virus type 16	71
The microbiome’s hidden influence: preclinical insights into inflammatory responses in necrotizing enterocolitis	68
Regulatory T lymphocytes as a therapy for ischemic stroke	63
Regenerating the uterus: translational advances in endometrial bioengineering and immunotherapeutics	61
Role of polyamines in intestinal mucosal barrier function	61
Immune checkpoint for pregnancy	59
Correction: Glycoprotein 2 as a gut gate keeper for mucosal equilibrium between inflammation and immunity	59
The role of vaccines in the COVID-19 pandemic: what have we learned?	58
Thromboinflammatory challenges in stroke pathophysiology	55
Immunization of preterm infants: current evidence and future strategies to individualized approaches	52
Towards multiomic analysis of oral mucosal pathologies	50
Publisher Correction: Epithelial recognition and elimination against aberrant cells	48
The duality of microchimerism and cancer in parous women: a review and evolutionary perspective	45
The role of microglia in early neurodevelopment and the effects of maternal immune activation	42
Clinical relevance of feto-maternal microchimerism in (hematopoietic stem cell) transplantation	42
Single-cell RNA-seq methods to interrogate virus-host interactions	42
CAF-immune cell crosstalk and its impact in immunotherapy	41
Dyslipidemia and female reproductive failures: perspectives on lipid metabolism and endometrial immune dysregulation	40
Immune biology of NSCLC revealed by single-cell technologies: implications for the development of biomarkers in patients treated with immunotherapy	38
Unveiling the immunopathology of stroke: a comprehensive view on brain-immune interaction	37
Revisiting transplant immunology through the lens of single-cell technologies	37

Beyond defence: Immune architects of ovarian health and disease	34
CAR T-cell behavior and function revealed by real-time imaging	34
Local anesthetics and immunotherapy: a novel combination to fight cancer	34
Arginine metabolism in myeloid cells in health and disease	32
Mothers and mosquitoes: climate change contributes to the spread of vector-borne pathogens posing a substantial threat to pregnant women	30
Role of mucosal IgA antibodies as novel therapies to enhance mucosal barriers	26
Beyond direct killing—novel cellular immunotherapeutic strategies to reshape the tumor microenvironment	26
Maternal lipids in overweight and obesity: implications for pregnancy outcomes and offspring’s body composition	25
Role of alarmins in poststroke inflammation and neuronal repair	25
Immune compartments at the brain’s borders in health and neurovascular diseases	25
Role of glia and extracellular matrix in controlling neuroplasticity in the central nervous system	24
Riding the storm: managing cytokine-related toxicities in CAR-T cell therapy	24
Proteomics to study cancer immunity and improve treatment	22
Gut microbiota-derived metabolites tune host homeostasis fate	22
Disease pathogenesis and barrier functions regulated by group 3 innate lymphoid cells	21
Single-cell high-dimensional imaging mass cytometry: one step beyond in oncology	19
Maternal and placental galectins: key players in the feto-maternal symbiotic tango	19
The sweet and the bitter sides of galectin-1 in immunity: its role in immune cell functions, apoptosis, and immunotherapies for cancer with a focus on T cells	18
Tumor microenvironment antigens	18
Neuroimaging is the new “spatial omic”: multi-omic approaches to neuro-inflammation and immuno-thrombosis in acute ischemic stroke	18
Glycoprotein 2 as a gut gate keeper for mucosal equilibrium between inflammation and immunity	16
The role of circulating cell-free DNA as an inflammatory mediator after stroke	16
Cell therapies for viral diseases: a new frontier	16
Intracellular galectin interactions in health and disease	16
The role of the mucosal barrier system in maintaining gut symbiosis to prevent intestinal inflammation	15
Heterogeneity of tissue-resident immunity across organs and in health and disease	15
IgE and non-IgE-mediated pathways in anaphylaxis	15
Physiological and immunological barriers in the lung	15
Novel immunotherapeutic combinations moving forward: the modulation of the immunosuppressive microenvironment	14